UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
 
FORM 11-K
 
FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS
AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
  X     ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2018
 
OR
 
__ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _______ to _______
 
COMMISSION FILE NUMBER 1-3619
 
A. Full title of the plan and the address of the plan, if different from that of the issuer named below:
 
PFIZER SAVINGS PLAN
FOR EMPLOYEES RESIDENT IN PUERTO RICO
 
B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
 
PFIZER INC.
235 EAST 42ND STREET
NEW YORK, NEW YORK 10017






PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO

Table of Contents

 
Page
 
 
Report of Independent Registered Public Accounting Firm
 
 
Financial Statements
 
Statements of Net Assets Available for Plan Benefits as of December 31, 2018 and 2017
Statement of Changes in Net Assets Available for Plan Benefits for the year ended December 31, 2018
Notes to Financial Statements
Beginning on page 4
 
 
Supplemental Schedule*
 
Schedule H, Line 4i - Schedule of Assets (Held at End of Year)
 
 
Exhibit Index
 
 
Signature
*Note:
Other schedules required by 29 CFR 2520.103-10 of the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974, as amended, have been omitted because they are not applicable.





Report of Independent Registered Public Accounting Firm


To the Plan Participants and Savings Plan Committee
Pfizer Savings Plan for Employees Resident in Puerto Rico:

Opinion on the Financial Statements

We have audited the accompanying statements of net assets available for plan benefits of the Pfizer Savings Plan for Employees Resident in Puerto Rico (the Plan) as of December 31, 2018 and 2017, the related statement of changes in net assets available for plan benefits for the year ended December 31, 2018, and the related notes (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the net assets available for plan benefits of the Plan as of December 31, 2018 and 2017, and the changes in net assets available for plan benefits for the year ended December 31, 2018, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Accompanying Supplemental Information

The supplemental information in the accompanying Schedule H, Line 4i – Schedule of Assets (Held at End of Year) as of December 31, 2018 has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.


/s/ KPMG LLP


We have served as the Plan’s auditor since 1990.

Memphis, Tennessee
June 17, 2019

1




PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
STATEMENTS OF NET ASSETS AVAILABLE FOR PLAN BENEFITS

 
 
As of December 31,
(THOUSANDS OF DOLLARS)
 
2018
 
2017
Assets
 
 
 
 
Investments, at fair value
 
 
 
 
Pfizer Inc. common stock
 
$
104,128

 
$
87,543

Pfizer Inc. preferred stock
 
2,941

 
2,525

Common/collective trust funds
 
229,126

 
244,683

Mutual funds
 
29,318

 
34,432

Total investments, at fair value
 
365,513


369,183

 
 
 
 
 
Receivables
 
 
 
 
Participant contributions
 
275

 
344

Company contributions
 
11,379

 
2,382

Notes receivable from participants
 
8,573

 
9,536

Securities sold
 
237

 
63

Interest and other
 
181

 
193

Total receivables
 
20,645


12,518

Total assets
 
386,158

 
381,701

 
 
 
 
 
Liabilities
 
 
 
 
Investment management fees payable
 
4

 
4

Total liabilities
 
4


4

Net assets available for plan benefits
 
$
386,154


$
381,696

Amounts may not add due to rounding.
See accompanying Notes to Financial Statements.

2



PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR PLAN BENEFITS

(THOUSANDS OF DOLLARS)
 
Year Ended December 31, 2018
Additions/(reductions) to net assets attributed to:
 
 
Investment income
 
 
Net appreciation in investments
 
$
3,499

Pfizer Inc. common stock dividends
 
3,264

Pfizer Inc. preferred stock dividends
 
67

Interest and dividend income from other investments
 
2,420

Total investment income
 
9,250

Interest income from notes receivable from participants
 
360

Less: Investment management, redemption and loan fees
 
(253
)
Net investment and interest income
 
9,357

 
 
 
Contributions
 
 
Participant
 
13,887

Company
 
15,604

Rollovers into the Plan
 
1,536

Total contributions
 
31,027

Total additions
 
40,384

 
 
 
Deductions from net assets attributed to:
 
 
Benefits paid to participants
 
35,926

 
 
 
Net increase
 
4,457

 
 
 
Net assets available for plan benefits
 
 
Beginning of year
 
381,696

End of year
 
$
386,154

Amounts may not add due to rounding.
See accompanying Notes to Financial Statements.

3



PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
NOTES TO FINANCIAL STATEMENTS





1. Description of the Plan

The following description of the Pfizer Savings Plan for Employees Resident in Puerto Rico (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.
General

The Plan is a defined contribution plan. Participation in the Plan is open to any employee of Pfizer Pharmaceuticals LLC (the Company or Plan Sponsor) or an affiliate which has, with the consent of the Plan Sponsor or Pfizer Inc. (the Parent), adopted the Plan and who is included within a group or class designated by the Plan Sponsor as set forth in the Plan document. The Plan excludes any employees covered by another Company-sponsored defined contribution plan. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (ERISA), and the New Puerto Rico Internal Revenue Code, Act No. 1 of January 31, 2011, as amended (the Puerto Rico Code).

On September 3, 2015, the Parent acquired Hospira, Inc. (Hospira). In connection with the acquisition, the Company adopted and assumed sponsorship of the Hospira Puerto Rico Retirement Savings Plan (Hospira PR Plan), effective September 3, 2015. On February 1, 2017, former Hospira Puerto Rico colleagues became eligible for the Plan, and the Hospira PR Plan was merged into the Plan on October 2, 2017.

Plan Administration

The Plan is administered by the Savings Plan Committee of the Parent (the Plan Administrator), the named fiduciary of the Plan. The Plan Administrator monitors and reports on (i) the selection and termination of the trustee, custodian, investment managers and other service providers to the Plan and (ii) the investment activity and performance of the Plan, with the exclusion of the Company stock funds, which are reviewed by an independent fiduciary appointed by the Savings Plan Committee.

Administrative Costs

Beginning in 2017, Plan participants pay quarterly fees from their account balances. These fees include general plan administrative fees and expenses, such as recordkeeping, trustee and investment reporting fees. The quarterly fee deductions take place on the first business day following the end of each quarter (and are deducted from any full account distribution occurring during a quarter). In addition, certain transaction fees such as check fees, loan fees and qualified domestic relations order fees are paid by Plan participants.

Contributions

Participants may contribute (i) 1% to 20% of their eligible compensation on a before-tax basis, up to the maximum before-tax amount permitted by the Puerto Rico Code; and (ii) 1% to 10% of their eligible compensation on an after-tax basis. For all participants, contributions of up to 3% of eligible compensation are matched 100% by the Company and the next 3% are matched 50% by the Company. Participant contributions in excess of 6% are not matched.

Company matching contributions are deposited into the Plan each quarter, rather than on each pay date. In addition, generally participants must be actively employed on the last day of the quarter to receive the match; however, if the participant separates from the Company prior to the last day of the quarter due to retirement (defined as at least age 55 with at least 10 years of service or age 65), death, or disability, such participant will receive the matching contribution. In January 2018 , the Company funded the fourth quarter 2017 Company matching contributions in the amount of approximately $1.2 million. In January 2019 , the Company funded the fourth quarter 2018 Company matching contributions in the amount of approximately $1.3 million. These contributions are reported in the Company contributions receivable in the accompanying statements of net assets available for plan benefits.

Total combined before-tax and after-tax contributions may not exceed 20% of a participant’s eligible compensation, but total after-tax contributions, including spillover from before-tax contributions, cannot exceed 10% of a participant’s eligible compensation. Contributions are subject to certain legal limits set forth by the Puerto Rico Department of the Treasury and the Puerto Rico Code.


4



PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
NOTES TO FINANCIAL STATEMENTS




The Plan includes a Retirement Savings Contribution (RSC), which is an additional annual Company-provided contribution based on age and years of service. With the exception of certain participants who are specifically excluded by the Plan terms, participants generally are eligible to receive the RSC. Effective January 1, 2018, the Parent froze its non-union U.S. and Puerto Rico defined benefit plans and began providing RSC eligibility for those active colleagues. The RSC contributions are deposited into the Plan annually following the close of the Plan year, usually in February. In general, participants must be actively employed on the last day of the year to receive the RSC; however, if the participant separates from the Company prior to the last day of the year due to retirement (defined as at least age 55 with at least 10 years of service or age 65), death, or disability, such participant will receive the RSC. In February 2018, the Company funded the RSC for Plan year 2017 in the amount of approximately $1.1 million. In February 2019, the Company funded the RSC for Plan year 2018 in the amount of approximately $10.1 million. These contributions are reported in the Company contributions receivable in the accompanying statements of net assets available for plan benefits.

Participant Accounts

Each participant’s account is credited with the participant’s contributions, the Company’s contributions and an allocation of Plan earnings/(losses). Allocations are based on participants’ account balances, as defined in the Plan document.

Vesting

Participants are immediately 100% vested in their contributions and all Company contributions with the exception of the RSC. For the RSC, participants are 100% vested after three years of credited service.

Forfeited Amounts

Forfeited nonvested accounts of terminated participants are generally used to reduce future Company contributions. At December 31, 2018 and 2017, forfeited nonvested accounts totaled approximately $57,000 and $13,000, respectively. In 2018, no forfeited nonvested accounts were used to reduce Company contributions.

Rollovers into the Plan

Participants may elect to roll over one or more account balances from Company-sponsored or other qualified plans into the Plan.

Investment Options

Each participant in the Plan elects to have his or her contributions and Company contributions invested in any one or a combination of investment funds in the Plan. Transfers between funds must be made in whole percentages or dollar amounts. Based on the investment option, certain short-term redemption fees or restrictions may apply. Any contributions for which the participant does not provide investment direction are invested in the participant’s Qualified Default Investment Alternative (QDIA), which is the Vanguard Target Retirement Fund based on the participant’s year of birth.

Eligibility

All employees of the Company who are employed within the Commonwealth of Puerto Rico are eligible to enroll in the Plan on their date of hire, except for certain employees who (i) are covered by a collective bargaining agreement and have not negotiated to participate in the Plan, (ii) are employed by an employee group not designated for participation in the Plan or (iii) are otherwise eligible for another Company-sponsored savings plan.

Notes Receivable from Participants

Participants may borrow from their account balances with the interest rate set at 1% above the prime rate. The minimum loan is $1,000 and the maximum amount is the lesser of (i) 50% of the vested account balance reduced by any current outstanding loan balance, or (ii) $50,000, reduced by the current outstanding loan balance. Loans must be repaid within five years, unless the funds are used to purchase a primary residence. Primary residence loans must be repaid within 15 years. Loans transferred to the Plan due to the merger of legacy plans into the Plan maintain the terms of the original plan. Interest rates on outstanding loans ranged from 3.25% to 9.50% at December 31, 2018 and 2017.

Interest paid by the participant is credited to the participant’s account. Interest income from notes receivable from participants is recorded by the trustee as earned in the investment funds in the same proportion as the original loan issuance. Repayments

5



PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
NOTES TO FINANCIAL STATEMENTS




may not necessarily be made to the same fund from which the amounts were borrowed. Repayments are credited to the applicable funds based on the participant’s investment elections at the time of repayment.

In the event of termination, participants will have 90 days to repay the outstanding loan balance or to set up recurring monthly payments before it is considered a distribution and subject to ordinary income tax in the year it is considered distributed. In addition, a 10% excise tax will generally apply if the participant is younger than age 59½ at the time the distribution occurs.

Payment of Benefits

Participants are entitled to receive distributions upon termination, and may be able to take voluntary, in-service withdrawals, which include hardship withdrawals. Mandatory distributions are made in accordance with Plan provisions.
2. Summary of Significant Accounting Policies

Basis of Accounting

The financial statements of the Plan are prepared on the accrual basis of accounting.

Some amounts in the financial statements, notes to financial statements and supplemental schedule of the Plan may not add due to rounding.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires Plan management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

Investment Valuation and Income Recognition

Common stock is valued at the closing market price on the last business day of the year. Mutual funds are recorded at fair value based on the closing market prices obtained from national exchanges of the underlying investments of the respective fund as of the last business day of the year. Common/collective trust funds (CCTs) are stated at redemption value as determined by the trustees of such funds based upon the underlying securities stated at fair value on the last business day of the year. The Plan generally has the ability to redeem its investments at the net asset value (NAV) at the valuation date. There are no significant restrictions, redemption terms or holding periods that would limit the ability of the Plan or the participants to transact at the NAV.

The per-share stated value of the Pfizer Inc. preferred stock is $40,300 and each share is convertible, at the holder’s option, into 2,574.87 shares of Pfizer Inc. common stock. The Pfizer Inc. preferred stock may also be redeemed by Pfizer Inc. at any time or upon termination of the employee stock ownership plan trust in which it is held, at Pfizer Inc.’s option, in cash, in shares of common stock or a combination of both at a price of $40,300 per share. Pfizer Inc. preferred stock share balances maintained by the Plan’s trustee and recordkeeper are on a basis equal to a multiple of 1,000 of the share balance and one-thousandth of the $40,300 stated value and are valued using either the higher of the per-share equivalent stated value of $40.30 ($40,300 stated value divided by 1,000) or the quoted market price on the New York Stock Exchange of Pfizer Inc. common stock multiplied by 2.57487 on the last business day of the Plan year. At December 31, 2018 and 2017, Pfizer Inc. preferred stock was valued at $112.39 per share and $93.26 per share, respectively, based on the closing Pfizer Inc. common stock price of $43.65 per share and $36.22 per share on December 31, 2018 and 2017, respectively.

See Note 4, Fair Value Measurements , for additional information regarding the fair value of the Plan’s investments.

Purchases and sales of securities are recorded on a trade-date basis. Dividend income is recorded on the ex-dividend date. Interest income is recorded as earned. The net appreciation/(depreciation) in the fair value of investments consists of the realized gains or losses on the sales of investments and the net unrealized appreciation/(depreciation) of investments.

Notes Receivable from Participants

Notes receivable from participants, which are subject to various interest rates, are recorded at amortized cost.


6



PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
NOTES TO FINANCIAL STATEMENTS




Payment of Benefits

Benefits are recorded when paid.

Subsequent Events

The Plan Sponsor has evaluated subsequent events from the statement of net assets available for plan benefits date through June 17, 2019 , the date at which the financial statements were available to be issued, and no events were noted which warrant adjustments to, or disclosure in, the financial statements.

Recently Issued Accounting Standard

In February 2017, the Financial Accounting Standards Board (FASB) issued new guidance on the presentation and disclosure requirements for employee benefit plans that hold interests in master trusts in the scope of Accounting Standards Codification (ASC) No 960, Plan Accounting – Defined Benefit Pension Plans , ASC 962, Plan Accounting – Defined Contribution Pension Plans , and ASC 965, Plan Accounting – Health and Welfare Benefit Plans . The new guidance requires a plan’s interests in master trust balances and activities be presented in separate line items in the statement of net assets available for plan benefits and in the statement of changes in net assets available for plan benefits. The new guidance also requires certain disclosures regarding the master trust’s investments and other assets and liabilities. The effective date is January 1, 2019 and earlier application is permitted. The Plan currently does not have any interests in master trusts that are within the scope of the new guidance.
3. Tax Status

The Puerto Rico Department of the Treasury has determined and informed the Plan Sponsor by letter dated February 17, 2017 that the Plan and related trust are designed in accordance with the applicable sections of the Puerto Rico Code.  Additionally, the Company’s counsel believes the Plan is currently designed and being operated in compliance with the applicable requirements of the Puerto Rico Code. Accordingly, no provision has been made for Puerto Rico income taxes in the accompanying financial statements.

U.S. GAAP requires Plan management to evaluate tax positions taken by the Plan and recognize a tax liability (or asset) if the Plan has taken an uncertain position that more likely than not would not be sustained upon examination by the Puerto Rico Department of the Treasury. The Company’s counsel has confirmed that there are no uncertain positions taken that would require recognition of a liability (or asset) or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress. The Plan Administrator believes the Plan is generally no longer subject to income tax examinations for years prior to 2015 .

4. Fair Value Measurements

The framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs to fair value measurements - Level 1 meaning the use of quoted prices for identical instruments in active markets; Level 2 meaning the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable; and Level 3 meaning the use of unobservable inputs.

See Note 2, Summary of Significant Accounting Policies: Investment Valuation and Income Recognition , for information regarding the methods used to determine the fair value of the Plan’s investments. These methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

7



PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
NOTES TO FINANCIAL STATEMENTS




The following tables set forth by level, within the fair value hierarchy, the Plan’s investments at fair value:
 
 
Fair Value as of December 31, 2018
(THOUSANDS OF DOLLARS)
 
Level 1
 
Level 2
 
Level 3
 
Total
Pfizer Inc. common stock
 
$
104,128

 
$

 
$

 
$
104,128

Pfizer Inc. preferred stock
 

 
2,941

 

 
2,941

Common/collective trust funds
 

 
229,126

 

 
229,126

Mutual funds
 
29,318

 

 

 
29,318

Total
 
$
133,446


$
232,067


$


$
365,513

 
 
Fair Value as of December 31, 2017
(THOUSANDS OF DOLLARS)
 
Level 1
 
Level 2
 
Level 3
 
Total
Pfizer Inc. common stock
 
$
87,543

 
$

 
$

 
$
87,543

Pfizer Inc. preferred stock
 

 
2,525

 

 
2,525

Common/collective trust funds
 

 
244,683

 

 
244,683

Mutual funds
 
34,432

 

 

 
34,432

Total
 
$
121,975


$
247,208


$


$
369,183

5. Related Party Transactions and Party-In-Interest Transactions

Banco Popular de Puerto Rico, the trustee of the Plan, is deemed a party-in-interest and a related party. Northern Trust manages investments in its sponsored funds and, therefore, is deemed a party-in-interest and a related party. Fidelity, the record keeper of the Plan, manages investments in its sponsored funds and, therefore, is deemed a party-in-interest and a related party. The Plan also invests in shares of the Parent; therefore, these transactions qualify as party-in-interest transactions.
6. Plan Termination

Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of termination of the Plan, each participant shall be entitled to the full value of his or her account balance as though he or she had retired as of the date of such termination. No part of the invested assets established pursuant to the Plan will at any time revert to the Company, except as otherwise permitted under ERISA.
7. Risks and Uncertainties

Investment securities, including Pfizer Inc. common and preferred stock, are exposed to various risks, such as interest rate, market and credit risks. Due to the level of risk associated with certain investment securities, it is at least reasonably possible that changes in their fair values will occur in the near term and that such changes could materially affect participants’ account balances and the amounts reported in the statements of net assets available for plan benefits.
8. Reconciliation of Financial Statements to Form 5500

Amounts allocated to withdrawing participants are recorded as benefits paid on Form 5500 for benefit claims that have been processed and approved for payment prior to December 31 st but not yet paid as of that date. Deemed distributions, representing withdrawing participants with outstanding loan balances for which no post-default payment activity has occurred, are not reported on Form 5500 in net assets available for plan benefits.
The following is a reconciliation of net assets available for plan benefits per the financial statements to the Form 5500:
 
 
Year Ended December 31,
(THOUSANDS OF DOLLARS)
 
2018
 
2017
Net assets available for plan benefits per the financial statements
 
$
386,154

 
$
381,696

Amounts allocated to withdrawing participants
 
(44
)
 
(98
)
Deemed distributions
 
(631
)
 
(537
)
Net assets available for plan benefits per Form 5500
 
$
385,479


$
381,061


8



PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
NOTES TO FINANCIAL STATEMENTS




The following is a reconciliation of benefits paid to participants, including rollovers, per the financial statements to the Form 5500:
(THOUSANDS OF DOLLARS)
 
Year Ended December 31, 2018
Benefits paid to participants, including rollovers, per the financial statements
 
$
35,926

Amounts allocated to withdrawing participants and deemed distributions at end of year
 
674

Amounts allocated to withdrawing participants and deemed distributions at beginning of year
 
(634
)
Benefits paid to participants, including rollovers, per Form 5500
 
$
35,966


9



PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
As of December 31, 2018
(THOUSANDS OF DOLLARS)
 
Identity of Issuer, Borrower, Lessor or Similar Party
 
Description of Investment
 
Rate of Interest
 
Maturity
Date
 
Cost**
 
Current Value
 
 
 
 
 
 
 
 
 
 
 
 
*
Pfizer Inc. Common Stock
 
Common stock
 
 
 
 
 
 
 
$
104,128

 
 
 
 
 
 
 
 
 
 
 
 
*
Pfizer Inc. Preferred Stock
 
Preferred stock
 
 
 
 
 
 
 
2,941

 
 
 
 
 
 
 
 
 
 
 
 
*
NTGI - S&P 500 Index Fund
 
Collective trust fund
 
 
 
 
 
 
 
43,828

*
NTGI - Russell 2000 Small Cap Index Fund
 
Collective trust fund
 
 
 
 
 
 
 
8,263

*
NTGI - Collective Government Short-Term
 
 
 
 
 
 
 
 
 
 
 
Investment Fund
 
Collective trust fund
 
 
 
 
 
 
 
939

 
BlackRock Mid Cap Equity Index Fund
 
Collective trust fund
 
 
 
 
 
 
 
15,085

 
BlackRock International Index Fund
 
Collective trust fund
 
 
 
 
 
 
 
851

*
Fidelity Large Cap Growth Fund
 
Collective trust fund
 
 
 
 
 
 
 
23,247

 
Oppenheimer Developing Markets Fund
 
Collective trust fund
 
 
 
 
 
 
 
3,539

 
Boston Partners Large Cap Value Fund
 
Collective trust fund
 
 
 
 
 
 
 
4,445

 
T. Rowe Price Stable Value Common Trust Fund
 
Collective trust fund
 
 
 
 
 
 
 
74,122

 
Vanguard Target Retirement Income Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
3,564

 
Vanguard Target Retirement 2015 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
942

 
Vanguard Target Retirement 2020 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
13,428

 
Vanguard Target Retirement 2025 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
3,460

 
Vanguard Target Retirement 2030 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
15,874

 
Vanguard Target Retirement 2035 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
6,239

 
Vanguard Target Retirement 2040 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
7,549

 
Vanguard Target Retirement 2045 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
2,053

 
Vanguard Target Retirement 2050 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
597

 
Vanguard Target Retirement 2055 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
843

 
Vanguard Target Retirement 2060 Trust Select
 
Collective trust fund
 
 
 
 
 
 
 
257

 
Total common/collective trust funds
 
 
 
 
 
 
 
 
 
229,126

 
 
 
 
 
 
 
 
 
 
 
 
 
T. Rowe Price Small Cap Stock Fund
 
Mutual fund
 
 
 
 
 
 
 
4,075

 
Dodge & Cox International Fund
 
Mutual fund
 
 
 
 
 
 
 
12,149

 
Diversified Bond Fund - Core
 
Mutual fund
 
 
 
 
 
 
 
11,476

 
Diversified Bond Fund - High Yield
 
Mutual fund
 
 
 
 
 
 
 
962

 
Diversified Bond Fund - Emerging Markets
 
Mutual fund
 
 
 
 
 
 
 
656

 
Total mutual funds
 
 
 
 
 
 
 
 
 
29,318

 
 
 
 
 
 
 
 
 
 
 
 
 
Total investments
 
 
 
 
 
 
 
 
 
365,513

 
 
 
 
 
 
 
 
 
 
 
 
*
Notes receivable from participants
 
Interest Rates: 3.25% - 9.50%
 
 
 
 
 
 
 
8,573

 
 
 
Maturity Dates: 2019- 2033
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
$
374,086

*
Party-in-interest as defined by ERISA
** Cost information omitted as all investments are fully participant-directed. This information is not required by ERISA or the Department of Labor to be reported for participant-directed investments.
See accompanying Report of Independent Registered Public Accounting Firm.



10



Exhibit Index
 
 
 
 
 
-
Consent of Independent Registered Public Accounting Firm


11



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the members of the Savings Plan Committee have duly caused this annual report to be signed on its behalf by the undersigned thereunto duly authorized.
PFIZER SAVINGS PLAN FOR EMPLOYEES RESIDENT IN PUERTO RICO
 
By:  /s/ Kevin Dillon
 
 
Kevin Dillon
Member, Savings Plan Committee
Date: June 17, 2019


12

Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024 Plus de graphiques de la Bourse Pfizer
Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024 Plus de graphiques de la Bourse Pfizer